**Eye Movement Abnormalities in Spinocerebellar Ataxias**

Roberto Rodríguez-Labrada and Luis Velázquez-Pérez *Centre for the Research and Rehabilitation of Hereditary Ataxias, Holguin Cuba* 

#### **1. Introduction**

58 Spinocerebellar Ataxia

Tsao, Y.P., Russo, A., Nyamuswa, G., Silber, R., and Liu, L.F. (1993). Interaction between

Wang, Y., Dawson, V.L., and Dawson, T.M. (2009). Poly(ADP-ribose) signals to mitochondrial

Wang, Y., Kim, N.S., Haince, J.F., Kang, H.C., David, K.K., Andrabi, S.A., Poirier, G.G.,

Westermann, B. (2010). Mitochondrial fusion and fission in cell life and death. Nat Rev Mol

Wu, J., and Liu, L.F. (1997). Processing of topoisomerase I cleavable complexes into DNA

Yakes, F.M., and Van Houten, B. (1997). Mitochondrial DNA damage is more extensive and

Zhang, H., Barcelo, J.M., Lee, B., Kohlhagen, G., Zimonjic, D.B., Popescu, N.C., and Pommier,

Zhang, H.F., Tomida, A., Koshimizu, R., Ogiso, Y., Lei, S., and Tsuruo, T. (2004). Cullin 3

Zhou, T., Akopiants, K., Mohapatra, S., Lin, P.S., Valerie, K., Ramsden, D.A., Lees-Miller, S.P.,

Zong, W.X., and Thompson, C.B. (2006). Necrotic death as a cell fate. Genes Dev *20*, 1-15.

with axonal neuropathy. Nat Genet *32*, 267-272.

(parthanatos). Sci Signal *4*, ra20.

Proc Natl Acad Sci U S A *94*, 514-519.

Cell Biol *11*, 872-884.

Cancer Res *64*, 1114-1121.

10613.

911.

SV40 DNA replication system. Cancer Res *53*, 5908-5914.

AIF: a key event in parthanatos. Exp Neurol *218*, 193-202.

damage by transcription. Nucleic Acids Res *25*, 4181-4186.

topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia

replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free

Dawson, V.L., and Dawson, T.M. (2011). Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death

persists longer than nuclear DNA damage in human cells following oxidative stress.

Y. (2001). Human mitochondrial topoisomerase I. Proc Natl Acad Sci U S A *98*, 10608-

promotes proteasomal degradation of the topoisomerase I-DNA covalent complex.

and Povirk, L.F. (2009). Tyrosyl-DNA phosphodiesterase and the repair of 3' phosphoglycolate-terminated DNA double-strand breaks. DNA Repair (Amst) *8*, 901Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal dominant neurodegenerative disorders characterized by a progressive cerebellar syndrome, variably associated to signs of brainstem involvement, pyramidal or extrapyramidal manifestations and cognitive dysfunctions, among other features that confer a remarkable wide range in phenotypes (Harding, 1983; Durr, 2010).

SCAs are associated with at least 31 different genetic loci, but the responsible gene is known in only 19 of them. Causative mutations include coding CAG expansions leading to a long polyglutamine (polyQ) tract in the respective proteins (SCA1, 2, 3, 6, 7 and 17), non-coding trinucleotide or pentanucleotide expansions (SCA8, 10, 12 and 31), as well as conventional mutations (SCA5, 11, 13, 14, 15/16, 20, 27 and 28) (Durr, 2010). The worldwide prevalence of SCAs is estimated near to 5-7 cases per 100 000 inhabitants but it can be higher in some regions due to foundational effects such as SCA2 in Holguín, Cuba (Velazquez-Pérez et al., 2009a) and SCA3 in Azores islands, Portugal (Vale et al., 2010).

Oculomotor disturbances are prominent features of SCA patients as result of cerebellar and brainstem neurodegeneration (Zee et al., 1976; Pula et al., 2010). The study of eye movement abnormalities give us valuable tools to search disease biomarkers because they can be easily accessible to clinical and/or electrophysiological evaluations and their dynamic properties and neurobiological basis are well known (Leigh & Kennard, 2004; Leigh & Zee, 2006; Reilly et al., 2008). The focus of this chapter is to review the state of the art of the eye movement deficits in SCAs, emphasizing in the usefulness of these features as disease biomarkers.

#### **2. Brief overview of eye movements**

Eye movements contribute to the clear vision stabilizing images on the retina, especially against movements of the head and body, capturing and keeping particular stimuli on the fovea and aligning the retinal images in the two eyes to guarantee the single vision and stereopsis. These functions can be achieved by 5 basic types of eye movements. For example, the image stabilization on the retina is promoted by the vestibulocular and optokinetic reflexes; the foveation occurs thorough the saccadic and smooth pursuit movements, whereas the binocular alignment is guaranteed by the vergence eye movements (Bruce & Friedman, 2002).

Eye Movement Abnormalities in Spinocerebellar Ataxias 61

current position of gaze. Saccades are the fastest eye movements, reaching up to 6000/s. There are close relationships between saccadic peak velocities, durations and amplitudes,

Behaviourally, the saccades may be classified as reexive guided saccades and intentional or volitional saccades. The first ones are evoked by the suddenly appearing targets, whereas the second ones, called also higher-order saccades, are made purposely, involve high cognitive processing and include voluntary, memory guided and delayed saccades as well

The neural basis of saccadic eye movements system comprises some cortico-cortical and cortico-subcortical networks (Müri & Nyffeler, 2008). Visual information processed in the primary visual cortex is send to higher cortical areas, such as parietal eye field (PEF) and frontal eye field (FEF), which are involved in the preparation and triggering of reflexive and intentional saccades respectively (Pierrot-Deseilligny, et al., 2004). These cortical areas project their output directly or through the basal ganglia, to superior colliculus, a midbrain structure that identifies the target in retinotopic coordinates, generates trigger signal to the brainstem premotor oculomotor circuitry and encodes the magnitude and direction of the desired eye movement. This information is projected to the cerebellum, via a pontine precerebellar nucleus, which guarantees the saccadic accuracy. Premotor burst neurons (PBN) for horizontal saccades lie within the paramedian pontine reticular formation (PPRF) while burst neurons for vertical and torsional saccades lie within the rostral interstitial nucleus of the medial longitudinal fasciculus. Saccade-related cerebellar areas include the oculomotor vermis (lobules VI and VII) and the caudal region of the fastigial nucleus which send saccade commands to the contralateral PBNs leading the activation of motorneurons and oculomotor muscles related with the desired saccadic movement (Leigh & Zee, 2006;

Smooth-pursuit eye movements enable us to maintain the image of a moving object relatively stable on or near the fovea by matching eye velocity to target velocity (Leigh & Zee, 2006). Smooth pursuit performance is optimal for target speeds ranging between 150/s and 300/s but pursuit velocity can reach up to 1000/s (Lencer & Trillenberg 2008; Bruce & Friedman, 2002). Smooth pursuit system is closely related to other oculomotor systems such as OKR and saccadic system. In fact, the small position errors raised when the tracking velocity is not properly matched to the target are corrected by saccadic movements named

Neuronal pathways for smooth pursuit movements involve a complex network of cortical and subcortical structures. Extrastriate visual area V5 (divided into middle temporal visual area (MT) and the medial superior temporal visual area (MST)) play a crucial role for motion perception and smooth pursuit control. This area receives visual motion information from the primary visual cortex in a retinotopic and ipsilaterally organized fashion. The MT area encodes image motion in a retinal coordinate system whereas MST area converts the signals into a spatial coordinate system. The signals generated in the V5 area are projected to other cortical areas in the parietal and frontal lobes. Among them, the frontal eye field (FEF) is involved in the generation of oculomotor command for smooth pursuit. Both visual motion

which represent the saccadic main sequence (Bahill et al., 1975, Ramat et al., 2007).

as antisaccades (Müri & Nyffeler, 2008; Leigh & Kennard, 2004).

Robinson & Fuchs, 2001; Prsa & Their, 2011; Voogd et al., 2011).

**2.4 Smooth pursuit movements** 

"catch up" saccades (Lencer & Trillenberg, 2007).

Eye movements differ in many aspects, such as their velocity, reaction time, reflexivity/volitional degree and their neurobiological substrate (Sparks, 2002). Nevertheless all have generic kinematic properties and share a common final path represented by three cranial nerve nuclei and the three pairs of eye muscles that they control (Bruce & Friedman, 2002; Leigh & Zee, 2006). Cranial nerve III (oculomotor) innervates superior, inferior and medial rectus muscles as well as the inferior oblique muscle, whereas troclear (IV) and abducens (VI) nerves innervate the superior oblique and lateral rectus respectively (Leigh & Zee, 2006).

Main features and neurophysiological bases of the 5 basic types of eye movements will be briefly addressed as follow.

#### **2.1 Vestibulocular reflex (VOR)**

The vestibulocular reflex (VOR) is elicited by the vestibular system in response to body/head rotations and consists in compensatory eye movements in opposite direction to body/head movement to guarantee the image stabilization on the retina (Aw et al., 1996). VOR depends of two neural circuits: *a)* Basic three neurons circuit and, *b)* Neural integrator circuit.

In the basic three neurons circuit, the head/body rotations are detected and transduced by vestibular ganglion neurons in the semicircular canal. Then, the transduced information is projected to neurons of the vestibular nuclei, located in the pons, and from there to oculomotor neurons (OMN) in one of the three oculomotor nuclei. Nevertheless, the three neurons circuit by itself is unable to adequately stabilize the image on the retina because it only generates phasic innervations of the oculomotor muscles, causing the return of the eye back to the central position due to the pulling of elastic forces. The neural integrator serves to exactly overcome this elastic force producing tonic innervations of oculomotor muscles. It is located in the *prepositus hypoglossi* and medial vestibular nuclei, which receive projections from the vestibular nuclei and have recurrent connections onto themselves. Some vestibular afferents go directly to the floculus/parafloculus cerebellar lobe, which is involved in VOR adaptation (Bruce & Friedman, 2002).

#### **2.2 Optokinetic reflex (OKR)**

When head/body rotations are very large and continued the VOR is depressed and thus it is complemented by the optokinetic reflex (OKR), in which the speed and direction of a fullfield image motion is computed to develop eye movements with two phases, an slow phase that alternates with resetting quick phase (Tusa & Zee, 1989). Pathway underlying OKR includes the nucleus of the optic tract, which receives visual motion signals from the contralateral eye and striate/extrastriate cortical areas. This information is send to the vestibular nuclei and to the inferior olivary nucleus, and then to the flocular/paraflocular Purkinje cells via their climbing bers (Bruce & Friedman, 2002).

#### **2.3 Saccadic eye movements**

Saccades are ballistic, conjugate eye movements that redirect fovea from one object of interest to another, allowing to explore accurately the visual scenes. For that, the saccadic system processes information about the distance and direction of a target image from the

Eye movements differ in many aspects, such as their velocity, reaction time, reflexivity/volitional degree and their neurobiological substrate (Sparks, 2002). Nevertheless all have generic kinematic properties and share a common final path represented by three cranial nerve nuclei and the three pairs of eye muscles that they control (Bruce & Friedman, 2002; Leigh & Zee, 2006). Cranial nerve III (oculomotor) innervates superior, inferior and medial rectus muscles as well as the inferior oblique muscle, whereas troclear (IV) and abducens (VI) nerves innervate the superior oblique and lateral rectus

Main features and neurophysiological bases of the 5 basic types of eye movements will be

The vestibulocular reflex (VOR) is elicited by the vestibular system in response to body/head rotations and consists in compensatory eye movements in opposite direction to body/head movement to guarantee the image stabilization on the retina (Aw et al., 1996). VOR depends of two neural circuits: *a)* Basic three neurons circuit and, *b)* Neural integrator

In the basic three neurons circuit, the head/body rotations are detected and transduced by vestibular ganglion neurons in the semicircular canal. Then, the transduced information is projected to neurons of the vestibular nuclei, located in the pons, and from there to oculomotor neurons (OMN) in one of the three oculomotor nuclei. Nevertheless, the three neurons circuit by itself is unable to adequately stabilize the image on the retina because it only generates phasic innervations of the oculomotor muscles, causing the return of the eye back to the central position due to the pulling of elastic forces. The neural integrator serves to exactly overcome this elastic force producing tonic innervations of oculomotor muscles. It is located in the *prepositus hypoglossi* and medial vestibular nuclei, which receive projections from the vestibular nuclei and have recurrent connections onto themselves. Some vestibular afferents go directly to the floculus/parafloculus cerebellar lobe, which is involved in VOR

When head/body rotations are very large and continued the VOR is depressed and thus it is complemented by the optokinetic reflex (OKR), in which the speed and direction of a fullfield image motion is computed to develop eye movements with two phases, an slow phase that alternates with resetting quick phase (Tusa & Zee, 1989). Pathway underlying OKR includes the nucleus of the optic tract, which receives visual motion signals from the contralateral eye and striate/extrastriate cortical areas. This information is send to the vestibular nuclei and to the inferior olivary nucleus, and then to the flocular/paraflocular

Saccades are ballistic, conjugate eye movements that redirect fovea from one object of interest to another, allowing to explore accurately the visual scenes. For that, the saccadic system processes information about the distance and direction of a target image from the

Purkinje cells via their climbing bers (Bruce & Friedman, 2002).

respectively (Leigh & Zee, 2006).

**2.1 Vestibulocular reflex (VOR)** 

adaptation (Bruce & Friedman, 2002).

**2.2 Optokinetic reflex (OKR)** 

**2.3 Saccadic eye movements** 

briefly addressed as follow.

circuit.

current position of gaze. Saccades are the fastest eye movements, reaching up to 6000/s. There are close relationships between saccadic peak velocities, durations and amplitudes, which represent the saccadic main sequence (Bahill et al., 1975, Ramat et al., 2007).

Behaviourally, the saccades may be classified as reexive guided saccades and intentional or volitional saccades. The first ones are evoked by the suddenly appearing targets, whereas the second ones, called also higher-order saccades, are made purposely, involve high cognitive processing and include voluntary, memory guided and delayed saccades as well as antisaccades (Müri & Nyffeler, 2008; Leigh & Kennard, 2004).

The neural basis of saccadic eye movements system comprises some cortico-cortical and cortico-subcortical networks (Müri & Nyffeler, 2008). Visual information processed in the primary visual cortex is send to higher cortical areas, such as parietal eye field (PEF) and frontal eye field (FEF), which are involved in the preparation and triggering of reflexive and intentional saccades respectively (Pierrot-Deseilligny, et al., 2004). These cortical areas project their output directly or through the basal ganglia, to superior colliculus, a midbrain structure that identifies the target in retinotopic coordinates, generates trigger signal to the brainstem premotor oculomotor circuitry and encodes the magnitude and direction of the desired eye movement. This information is projected to the cerebellum, via a pontine precerebellar nucleus, which guarantees the saccadic accuracy. Premotor burst neurons (PBN) for horizontal saccades lie within the paramedian pontine reticular formation (PPRF) while burst neurons for vertical and torsional saccades lie within the rostral interstitial nucleus of the medial longitudinal fasciculus. Saccade-related cerebellar areas include the oculomotor vermis (lobules VI and VII) and the caudal region of the fastigial nucleus which send saccade commands to the contralateral PBNs leading the activation of motorneurons and oculomotor muscles related with the desired saccadic movement (Leigh & Zee, 2006; Robinson & Fuchs, 2001; Prsa & Their, 2011; Voogd et al., 2011).

#### **2.4 Smooth pursuit movements**

Smooth-pursuit eye movements enable us to maintain the image of a moving object relatively stable on or near the fovea by matching eye velocity to target velocity (Leigh & Zee, 2006). Smooth pursuit performance is optimal for target speeds ranging between 150/s and 300/s but pursuit velocity can reach up to 1000/s (Lencer & Trillenberg 2008; Bruce & Friedman, 2002). Smooth pursuit system is closely related to other oculomotor systems such as OKR and saccadic system. In fact, the small position errors raised when the tracking velocity is not properly matched to the target are corrected by saccadic movements named "catch up" saccades (Lencer & Trillenberg, 2007).

Neuronal pathways for smooth pursuit movements involve a complex network of cortical and subcortical structures. Extrastriate visual area V5 (divided into middle temporal visual area (MT) and the medial superior temporal visual area (MST)) play a crucial role for motion perception and smooth pursuit control. This area receives visual motion information from the primary visual cortex in a retinotopic and ipsilaterally organized fashion. The MT area encodes image motion in a retinal coordinate system whereas MST area converts the signals into a spatial coordinate system. The signals generated in the V5 area are projected to other cortical areas in the parietal and frontal lobes. Among them, the frontal eye field (FEF) is involved in the generation of oculomotor command for smooth pursuit. Both visual motion

Eye Movement Abnormalities in Spinocerebellar Ataxias 63

hypermetria is observed in majority of the cases, appears at an early stage of the disease and progresses quickly (Klostermann et al., 1997; Rivaud-Pechoux et al., 1998; Buttner et al., 1998). The overshoot of saccades may reach values greater than 30% in comparison with

Brainstem oculomotor signs such as saccadic slowing or ophthalmoparesis are observed in 74% (Schmitz-Hübsch, et al., 2008). Reduction of saccade velocity can be detected in mildly affected patients and it is accentuated with the disease duration. Advanced patients may show ophthalmoparesis or severe saccadic slowing, so that saccadic hypermetria is less noticeable in comparison to early stages (Klostermann et al., 1997). Abnormal prolongation of saccadic latency occurs in 67% of cases (Buttner et al., 1998), whereas the execution of the antisaccadic task shows increased error rates, suggesting the presence of neurodegenerative

Reduced gain of smooth pursuit and OKN is noticed in 92% of SCA1 cases with the lowest smooth pursuit gains in comparison to SCA2 and SCA3 patients and comparable values of OKN gains to SCA2 (Burk et al., 1998). The progressive saccadic slowing causes the diminution of catch up saccades during visual tracking, leading to decrease of the smooth pursuit amplitudes on advanced disease (Buttner et al., 1998, Klostermann et al., 1997). Regarding vestibular functions, SCA1 patients are usually characterized by reduced VOR gains, which distinguish this SCA subtype from SCA2 but neither from SCA3 nor SCA6

No oculomotor abnormalities of SCA1 patients correlate with the number of CAG repeats (Burk et al., 1999; Rivaud-Pechoux et al.,1998), suggesting that they are not under significant

The most common oculomotor sign in patients with SCA2 is a significant reduction in horizontal saccadic eye velocity owing to brainstem involvement. This feature called attention to Wadia and Swami when made the first report of SCA2 in 1971, so that they described the disease as "*a new form of heredofamilial spinocerebellar degeneration with slow eye movements*" (Wadia & Swami, 1971). Several clinical and epidemiological studies have confirmed the high frequency of this saccadic alteration in more than 80% of cases (Velazquez-Pérez et al., 2009a; Orozco et al., 1989; Cancel et al., 1997, Wadia et al., 1998;

The first electronystagmographical evaluation of SCA2 patients was conducted by Kulkarni & Wadia in 1975 who found a relative decrease of saccadic velocity up to 25% in comparison with controls (Kulkarni & Wadia, 1975). Furthermore, comparative studies of oculomotor phenotypes among patients with cerebellar ataxias demonstrated that saccadic slowing is more prominent in SCA2 patients in comparison with SCA1, SCA3, SCA6 (Burk, et al; 1999; Buttner et al., 1998; Rivaud-Pechoux et al., 1998) and late onset cerebellar ataxia (Rufa & Federighi, 2011) giving an important diagnostic value to this oculomotor feature for SCA2. A comprehensive electronystagmographical study developed in 82 SCA2 Cuban patients showed little overlap between maximal saccadic velocity (MSV) values of SCA2 patients and controls. This study demonstrated a high sensitivity for SCA2 diagnosis assessed by a

normal subjects (Buttner et al., 1998).

(Burk et al., 1998; Buttner et al., 1998).

**3.2 Spinocerebellar ataxia type 2 (SCA2)** 

Schmitz-Hübsch, et al., 2008).

changes in the frontal cortex (Rivaud-Pechoux et al., 1998).

genetic control but are more dependent on disease duration.

signals and oculomotor commands are relayed to oculomotor parts of the cerebellum, through the dorsolateral and medial pontine nuclei. Smooth pursuit-related areas of the cerebellum comprise the paraocculus, the occulus, the oculomotor vermis and the uvula, which control the initiation and maintenance of smooth pursuit. Finally, the cerebellar output is projected, via the vestibular nuclei, to the oculomotor nuclei (Lencer & Trillenberg, 2007; Mustari et al., 2009).

#### **2.5 Vergence eye movements**

Vergence eye movements are disjunctive movements that provide the binocular alignment in response to changing xation target distances, requiring that both eyes point in contrary directions (Zee & Levi, 1989). Vergence movements are elicited by retinal disparity (when a fixation target is not on both foveae) and retinal blur (when a target is not in focus) and are closely related to the lens accommodation and pupillary reflexes. Although the neural basis of vergence eye movements are not well understood, it is known that both the retinal disparity and the retinal blur signals are processed by cortical visual areas such as primary visual cortex (V1) and an anterior region of the FEF. Additionally, it is presumed an important role of the oculomotor nucleus (III) for vergence movements, due to its known relation to lens accommodation and pupillary reflexes (Vilis, 1997; Bruce & Friedman, 2002). The cerebellum is involved in the processing of dynamic vergence eye movements (Sander et al., 2009). Cerebellar regions related with these disconjugate eye movements lie on the dorsal paraflocculus, and the floccular lobe, which project to the lateral portion of the posterior interposed nucleus (Voogd et al., 2011).

#### **2.6 Oculomotor disturbances**

Oculomotor disturbances can be topographically classified as peripheral or central disturbances. Peripheral abnormalities result from lesions in the oculomotor muscles or nerves, whereas the central disturbances are caused by lesions in the brainstem, cerebellum or other higher-level centers (Karatas, 2009). Oculomotor signs of cerebellar impairment include pathological nystagmus such as downbeat, rebound and periodic alternating nystagmus, as well as abnormal pursuit, VOR/OKR abnormalities and saccadic dysmetria (Robinson & Fuchs, 2001; Strupp et al., 2011). Whereas, brainstem involvement produces slowed vertical, torsional or horizontal saccades, ophthalmoplegia, VOR/OKR impairments and gaze-evoked nystagmus (Rüb et al., 2008, Strupp et al., 2011). Affectations in the basal ganglia can lead to reduced ability to initiate voluntary eye movements and to suppress unwanted saccades, in addition to decits in memory-guided saccades, eye-head coordination and eye-hand coordination (Hikosaka et al., 2000; Shires et al., 2010). Frontal cortex lesions produce prolongation of saccadic latency, impaired ability to make saccades to remembered target locations and errors on the antisaccade task, as well as delayed initiation of smooth pursuit and increase of catch up saccades (Pierrot-Deseilligny et al., 2004; Thurtell et al., 2007; Karatas, 2009).

#### **3. Oculomotor findings of spinocerebellar ataxias**

#### **3.1 Spinocerebellar ataxia type 1 (SCA1)**

The main eye movement abnormalities of SCA1 patients include saccadic dysmetria, gaze evoked nystagmus and depressed smooth pursuit (Matilla-Dueñas et al., 2008). Saccadic

signals and oculomotor commands are relayed to oculomotor parts of the cerebellum, through the dorsolateral and medial pontine nuclei. Smooth pursuit-related areas of the cerebellum comprise the paraocculus, the occulus, the oculomotor vermis and the uvula, which control the initiation and maintenance of smooth pursuit. Finally, the cerebellar output is projected, via the vestibular nuclei, to the oculomotor nuclei (Lencer & Trillenberg,

Vergence eye movements are disjunctive movements that provide the binocular alignment in response to changing xation target distances, requiring that both eyes point in contrary directions (Zee & Levi, 1989). Vergence movements are elicited by retinal disparity (when a fixation target is not on both foveae) and retinal blur (when a target is not in focus) and are closely related to the lens accommodation and pupillary reflexes. Although the neural basis of vergence eye movements are not well understood, it is known that both the retinal disparity and the retinal blur signals are processed by cortical visual areas such as primary visual cortex (V1) and an anterior region of the FEF. Additionally, it is presumed an important role of the oculomotor nucleus (III) for vergence movements, due to its known relation to lens accommodation and pupillary reflexes (Vilis, 1997; Bruce & Friedman, 2002). The cerebellum is involved in the processing of dynamic vergence eye movements (Sander et al., 2009). Cerebellar regions related with these disconjugate eye movements lie on the dorsal paraflocculus, and the floccular lobe, which project to the lateral portion of the

Oculomotor disturbances can be topographically classified as peripheral or central disturbances. Peripheral abnormalities result from lesions in the oculomotor muscles or nerves, whereas the central disturbances are caused by lesions in the brainstem, cerebellum or other higher-level centers (Karatas, 2009). Oculomotor signs of cerebellar impairment include pathological nystagmus such as downbeat, rebound and periodic alternating nystagmus, as well as abnormal pursuit, VOR/OKR abnormalities and saccadic dysmetria (Robinson & Fuchs, 2001; Strupp et al., 2011). Whereas, brainstem involvement produces slowed vertical, torsional or horizontal saccades, ophthalmoplegia, VOR/OKR impairments and gaze-evoked nystagmus (Rüb et al., 2008, Strupp et al., 2011). Affectations in the basal ganglia can lead to reduced ability to initiate voluntary eye movements and to suppress unwanted saccades, in addition to decits in memory-guided saccades, eye-head coordination and eye-hand coordination (Hikosaka et al., 2000; Shires et al., 2010). Frontal cortex lesions produce prolongation of saccadic latency, impaired ability to make saccades to remembered target locations and errors on the antisaccade task, as well as delayed initiation of smooth pursuit and increase of catch up saccades (Pierrot-Deseilligny et al.,

The main eye movement abnormalities of SCA1 patients include saccadic dysmetria, gaze evoked nystagmus and depressed smooth pursuit (Matilla-Dueñas et al., 2008). Saccadic

2007; Mustari et al., 2009).

**2.5 Vergence eye movements** 

**2.6 Oculomotor disturbances** 

2004; Thurtell et al., 2007; Karatas, 2009).

**3.1 Spinocerebellar ataxia type 1 (SCA1)** 

**3. Oculomotor findings of spinocerebellar ataxias** 

posterior interposed nucleus (Voogd et al., 2011).

hypermetria is observed in majority of the cases, appears at an early stage of the disease and progresses quickly (Klostermann et al., 1997; Rivaud-Pechoux et al., 1998; Buttner et al., 1998). The overshoot of saccades may reach values greater than 30% in comparison with normal subjects (Buttner et al., 1998).

Brainstem oculomotor signs such as saccadic slowing or ophthalmoparesis are observed in 74% (Schmitz-Hübsch, et al., 2008). Reduction of saccade velocity can be detected in mildly affected patients and it is accentuated with the disease duration. Advanced patients may show ophthalmoparesis or severe saccadic slowing, so that saccadic hypermetria is less noticeable in comparison to early stages (Klostermann et al., 1997). Abnormal prolongation of saccadic latency occurs in 67% of cases (Buttner et al., 1998), whereas the execution of the antisaccadic task shows increased error rates, suggesting the presence of neurodegenerative changes in the frontal cortex (Rivaud-Pechoux et al., 1998).

Reduced gain of smooth pursuit and OKN is noticed in 92% of SCA1 cases with the lowest smooth pursuit gains in comparison to SCA2 and SCA3 patients and comparable values of OKN gains to SCA2 (Burk et al., 1998). The progressive saccadic slowing causes the diminution of catch up saccades during visual tracking, leading to decrease of the smooth pursuit amplitudes on advanced disease (Buttner et al., 1998, Klostermann et al., 1997). Regarding vestibular functions, SCA1 patients are usually characterized by reduced VOR gains, which distinguish this SCA subtype from SCA2 but neither from SCA3 nor SCA6 (Burk et al., 1998; Buttner et al., 1998).

No oculomotor abnormalities of SCA1 patients correlate with the number of CAG repeats (Burk et al., 1999; Rivaud-Pechoux et al.,1998), suggesting that they are not under significant genetic control but are more dependent on disease duration.

#### **3.2 Spinocerebellar ataxia type 2 (SCA2)**

The most common oculomotor sign in patients with SCA2 is a significant reduction in horizontal saccadic eye velocity owing to brainstem involvement. This feature called attention to Wadia and Swami when made the first report of SCA2 in 1971, so that they described the disease as "*a new form of heredofamilial spinocerebellar degeneration with slow eye movements*" (Wadia & Swami, 1971). Several clinical and epidemiological studies have confirmed the high frequency of this saccadic alteration in more than 80% of cases (Velazquez-Pérez et al., 2009a; Orozco et al., 1989; Cancel et al., 1997, Wadia et al., 1998; Schmitz-Hübsch, et al., 2008).

The first electronystagmographical evaluation of SCA2 patients was conducted by Kulkarni & Wadia in 1975 who found a relative decrease of saccadic velocity up to 25% in comparison with controls (Kulkarni & Wadia, 1975). Furthermore, comparative studies of oculomotor phenotypes among patients with cerebellar ataxias demonstrated that saccadic slowing is more prominent in SCA2 patients in comparison with SCA1, SCA3, SCA6 (Burk, et al; 1999; Buttner et al., 1998; Rivaud-Pechoux et al., 1998) and late onset cerebellar ataxia (Rufa & Federighi, 2011) giving an important diagnostic value to this oculomotor feature for SCA2.

A comprehensive electronystagmographical study developed in 82 SCA2 Cuban patients showed little overlap between maximal saccadic velocity (MSV) values of SCA2 patients and controls. This study demonstrated a high sensitivity for SCA2 diagnosis assessed by a

Eye Movement Abnormalities in Spinocerebellar Ataxias 65

Fig. 1. Saccadic slowing in SCA2. A) Relationship of saccadic velocity and amplitudes in SCA2 patients. Show the significant reduction of saccadic velocity in almost all subjects. Dark lines represent the saccadic velocity ± 2 SD of controls. B) Influence of CAG repeat size

of visual information (Kremlacek et al., 2011) or in the visual-spatial attention (Le Pira et al.,

(A) (B)

test (WSCT) and the number of correct responses in the phonemic verbal test.

Fig. 2. Saccadic latency correlates with frontal-executive dysfunctions in SCA2 patients. Correlation analyses of saccadic latency with achieved categories in the Wisconsin sort card

on the saccadic velocity.

2002).

receiver operating characteristic (ROC) yielding an area under the curve of 0.99. The most important finding of this work was the significant influence of the number of CAG repeats, but not of disease duration, on saccadic velocity (Figure 1). According to this relationship, patients with larger expansions showed more saccadic slowing, identifying the saccadic velocity as the main variable endophenotype of the SCA2, which is under strong genetic control and therefore it may be considered as a sensitive biomarker for the study of polyglutamine toxicity. Also, MSV was negatively correlated with the total score of a cerebellar ataxia scale suggesting its association with the severity of the cerebellar syndrome (Velázquez et al., 2004). Other study performed in Cuban SCA2 patients revealed a closer relationship between the saccadic velocity and the visuomotor learning capabilities assessed by a prism adaptation task (Fernandez-Ruiz, et al., 2007).

A preliminary follow-up evaluation of saccadic slowing after one year in 30 SCA2 patients revealed no significant changes of MSV (Seifried et al., 2004). Nevertheless, other follow-up study during a larger period time it is being conducted in a large Cuban SCA2 cohort.

The saccadic slowing appears during the presymptomatic stage of the disease only for 60° target amplitude, but asymptomatic subjects carrying full-penetrant CAG expansions (≥36) show reduced MSV values even for 30°. In fact, the MSV reduction is stronger in carriers of large expansions. This preclinical feature progresses insidiously and it correlates with predicted time to clinical manifestation, which classifies this variable as a preclinical biomarker of high values for diagnosis and prognosis of the disease (Velázquez-Pérez et al., 2009b).

The neuroanatomical basis of this disorder has been elucidated by post-mortem studies that demonstrated the marked loss of excitatory PBN in the PPRF (Buttner-Ennever, et al., 1985; Geiner et al., 2008), the structure that coordinates the horizontal saccades (Leigh & Zee, 2006). Early, Gierga et al, 2005 had reported a significant neuronal death in the abducens (cranial nerve VI) and oculomotor nucleus (cranial nerve III), which innervate the oculomotor muscles responsible for eye movements in the horizontal plane (Leigh & Zee, 2006).

Hypometric saccades to extreme gaze positions are usual in SCA2 patients (Velázquez, 2008), nevertheless for short target amplitudes the saccade accuracy is maintained, although some patients can make hypermetric saccades. It has been suggested that as SCA2 patients having slow saccades that are no longer ballistic, visual feedback might be continuously available during the movement execution to guide the eye to its target rendering accurate short saccades (Federighi et al., 2011).

A recent electronystagmographical study in 110 SCA2 patients demonstrated the significant prolongation of saccadic latency in 46% of SCA2 patients. This variable was neither influenced by the CAG repeats, disease duration nor ataxia score, but it was close related with the neuropsychological performance of frontal-executive tasks, which highlights the saccadic latency as sensitive biomarker of cognitive disorders in SCA2 (Rodríguez-Labrada, et al., 2011a). Additionally, SCA2 patients show increased antisaccadic error rate (Rivaud-Pechoux et al., 1998). The delayed saccade onset and antisaccadic deficits could be explained by the severe gyral atrophy and neuronal loss in the frontal lobes and neurodegenerative changes in caudate nucleus and substantia nigra (Orozco et al., 1989; Durr et al., 1995; Estrada et al., 1999; Gierga et al., 2005), as well as deficits in the processing

receiver operating characteristic (ROC) yielding an area under the curve of 0.99. The most important finding of this work was the significant influence of the number of CAG repeats, but not of disease duration, on saccadic velocity (Figure 1). According to this relationship, patients with larger expansions showed more saccadic slowing, identifying the saccadic velocity as the main variable endophenotype of the SCA2, which is under strong genetic control and therefore it may be considered as a sensitive biomarker for the study of polyglutamine toxicity. Also, MSV was negatively correlated with the total score of a cerebellar ataxia scale suggesting its association with the severity of the cerebellar syndrome (Velázquez et al., 2004). Other study performed in Cuban SCA2 patients revealed a closer relationship between the saccadic velocity and the visuomotor learning capabilities assessed

A preliminary follow-up evaluation of saccadic slowing after one year in 30 SCA2 patients revealed no significant changes of MSV (Seifried et al., 2004). Nevertheless, other follow-up study during a larger period time it is being conducted in a large Cuban SCA2 cohort.

The saccadic slowing appears during the presymptomatic stage of the disease only for 60° target amplitude, but asymptomatic subjects carrying full-penetrant CAG expansions (≥36) show reduced MSV values even for 30°. In fact, the MSV reduction is stronger in carriers of large expansions. This preclinical feature progresses insidiously and it correlates with predicted time to clinical manifestation, which classifies this variable as a preclinical biomarker of high values for diagnosis and prognosis of the disease (Velázquez-Pérez et al.,

The neuroanatomical basis of this disorder has been elucidated by post-mortem studies that demonstrated the marked loss of excitatory PBN in the PPRF (Buttner-Ennever, et al., 1985; Geiner et al., 2008), the structure that coordinates the horizontal saccades (Leigh & Zee, 2006). Early, Gierga et al, 2005 had reported a significant neuronal death in the abducens (cranial nerve VI) and oculomotor nucleus (cranial nerve III), which innervate the oculomotor muscles responsible for eye movements in the horizontal plane (Leigh & Zee,

Hypometric saccades to extreme gaze positions are usual in SCA2 patients (Velázquez, 2008), nevertheless for short target amplitudes the saccade accuracy is maintained, although some patients can make hypermetric saccades. It has been suggested that as SCA2 patients having slow saccades that are no longer ballistic, visual feedback might be continuously available during the movement execution to guide the eye to its target rendering accurate

A recent electronystagmographical study in 110 SCA2 patients demonstrated the significant prolongation of saccadic latency in 46% of SCA2 patients. This variable was neither influenced by the CAG repeats, disease duration nor ataxia score, but it was close related with the neuropsychological performance of frontal-executive tasks, which highlights the saccadic latency as sensitive biomarker of cognitive disorders in SCA2 (Rodríguez-Labrada, et al., 2011a). Additionally, SCA2 patients show increased antisaccadic error rate (Rivaud-Pechoux et al., 1998). The delayed saccade onset and antisaccadic deficits could be explained by the severe gyral atrophy and neuronal loss in the frontal lobes and neurodegenerative changes in caudate nucleus and substantia nigra (Orozco et al., 1989; Durr et al., 1995; Estrada et al., 1999; Gierga et al., 2005), as well as deficits in the processing

by a prism adaptation task (Fernandez-Ruiz, et al., 2007).

2009b).

2006).

short saccades (Federighi et al., 2011).

Fig. 1. Saccadic slowing in SCA2. A) Relationship of saccadic velocity and amplitudes in SCA2 patients. Show the significant reduction of saccadic velocity in almost all subjects. Dark lines represent the saccadic velocity ± 2 SD of controls. B) Influence of CAG repeat size on the saccadic velocity.

of visual information (Kremlacek et al., 2011) or in the visual-spatial attention (Le Pira et al., 2002).

Fig. 2. Saccadic latency correlates with frontal-executive dysfunctions in SCA2 patients. Correlation analyses of saccadic latency with achieved categories in the Wisconsin sort card test (WSCT) and the number of correct responses in the phonemic verbal test.

Eye Movement Abnormalities in Spinocerebellar Ataxias 67

changes seen in the raphe interpositus nucleus (Rub et al., 2003), a key structure of the brainstem premotor network that contains the omnipausas neurons, a group of cells that play an important role in determining the size of the velocity command for saccades, beside their well-known role as gating saccades (Miura & Optican, 2006). Also, internuclear and nuclear ophthalmoplegia is observed in 53% and 10% of the cases respectively. The latter is

Finally, the prolongation of saccadic latency occurs late in few cases (14%) (Buttner et al., 1998) and the performance in the antisaccadic paradigm shows an increase in the number of

Oculomotor function of SCA6 patients is characterized by signs of cerebellar and vestibular impairments such as horizontal and vertical nystagmus, abnormal smooth pursuit, saccadic dysmetria and abnormal VOR (Buttner et al., 1998; Christova et al., 2008; Bour et al., 2008). In comparison with other SCAs, the spontaneous downbeat nystagmus and square-wave jerks have the higher incidence in SCA6 subjects, whereas gaze-evoked nystagmus, rebound nystagmus and periodic alternating nystagmus are common features too (Buttner

Patients with SCA6 have the more severe pursuit, OKN and VOR-fixed deficits among other polyglutamine SCAs but these oculomotor signs are not directly associated to CAG repeats or disease duration (Buttner et al., 1998). Vertical pursuit is impaired more than horizontal

The pattern of saccadic dysmetria in SCA6 is variable since these patients can show both hypometric and hypermetric saccades (Buttner et al., 1998; Bour et al., 2008). Although the decrease of saccadic velocity is not a prominent sign in these patients, it has been reported a mild saccadic slowing in some subjects both for the horizontal and vertical planes (Bour et al., 2008). These findings suggest functional extracerebellar impairment in the saccadic system and therefore are opposed to the paradigm of SCA6 as a "pure cerebellar syndrome." In fact, the screening of non-ataxia signs reveals a 25% of brainstem oculomotor signs (Schmitz-Hübsch, et al., 2008). In these patients the saccadic latency is normal (Buttner et al.,

In 2009, Christova and co-workers studied the eye movement's abnormalities in both symptomatic and asymptomatic SCA6 cohorts and noticed that square-wave jerks, saccadic abnormalities and depressed smooth pursuit can be detected even before the disease onset. Among them, the square-wave jerks were the most prominent with an apparition frequency

The major saccadic alteration in this SCA is the slowing of saccades, together with saccadic dysmetria (Miller et al., 2009; Manrique et al., 2009). The decrease in saccadic velocity in SCA7 is associated with marked pontine atrophy that characterizes these patients from early stages of the disease and progresses to produce significant external ophthalmoplegia in patients with longer disease history (Bang et al., 2004; Martin et al., 1999). These alterations

associated with a more severe disease course (Jardim et al., 2001).

whereas downward pursuit more than upward (Bour et al., 2008).

errors (Rivaud-Pechoux et al., 1998).

**3.4 Spinocerebellar ataxia type 6 (SCA6)** 

et al., 1998; Colen et al., 2008; Kim et al., 2010).

1998).

of 80% (Christova et al., 2008).

**3.5 Spinocerebellar ataxia type 7 (SCA7)** 

Other oculomotor alterations include ofthalmoplegia, which usually appears at advanced disease in the 45% of the cases, although the severe saccadic slowing might overlook the frequency of ofthalmoplegia in SCA2. These patients have mild reduction of smooth pursuit gain in correspondence with the atrophy of cerebellar floculus (Ying et al., 2006) and the decrease of catch up saccades. The physiological and pathological nystagmus are very rare in SCA2 due to impaired ability to produce saccadic corrective phases. Some SCA2 patients have VOR responses with reduced gain (Burk et al., 1999; Rivaud-Pechoux et al., 1998; Buttner et al., 1998).

Saccadic eye movements have also been used to evaluate the efficacy of therapeutical alternatives in Cuban SCA2 patients, such as neurorehabilitation (Rodríguez et al., 2008) and oral supplementation with zinc-sulphate (Velázquez-Pérez et al, 2011a). In both cases the saccadic latency decreased significantly after the therapies, but saccadic velocity and dysmetria were unchanged.

For SCA2, the oculomotor function has not only evaluated in wake state, since the density of rapid eye movements (saccadic) during REM sleep was recently assessed. Both symptomatic and presymptomatic subjects show a marked decrease in this parameter, which is negatively correlated with the ataxia score in the patients (Velázquez-Pérez, et al., 2011b; Rodríguez-Labrada et al., 2011b). These findings suggest the usefulness of saccadic density during REM sleep as progression marker of the disease and reflect the extension of the oculomotor brainstem involvement to the sleep.

#### **3.3 Spinocerebellar ataxia type 3 (SCA3)**

Pathological nystagmus are prominent oculomotor signs of SCA3 patients. The frequency of gaze evoked and rebound nystagmus is approximately 90% (Jardim et al., 2001) being higher than those in SCA1, SCA2 and SCA6. Square wave jerks are usually reported in SCA3 subjects, unlike SCA1 and SCA2 individuals (Buttner et al, 1998; Burk et al., 1998). This oculomotor sign results from cerebellar disease and consists in small, horizontal, saccade-like movements that lead the eye away from the target trajectory and, after a delay, bring it back onto the target (Leigh & Zee, 2006).

Decreased VOR gain can be detected in majority of SCA3 patients and correlates with the CAG repeats, suggesting the pathologic involvement of the vestibular nuclei in the lateral brainstem. Furthermore, these patients show reduction of smooth pursuit and OKR gains with a presentation frequency above 70% in both cases (Buttner et al, 1998; Burk et al., 1998).

Upon saccades, the main abnormality is saccadic dysmetria. Nevertheless, there are apparently conflicting data regarding the predominant type of dysmetria. Buttner et al., 1998 reported hypermetric saccades in 86% of the cases, while Rivauld-Pechoux et al., 1998, observed a predominance of hypometric (56%) over hypermetric saccades (18%). The disagreement can be explained by differences in the clinical stage of studied patients. In fact, the 81% of the patients recruited by Rivauld-Pechoux and colleagues had a moderate to severe motor disability, which could explain the higher prevalence of saccadic hypometria.

Different to SCA2 and SCA1, decreased saccadic velocity is not a common feature of SCA3 patients (Burk et al., 1999; Rivaud-Pechoux et al., 1998; Buttner et al., 1998). This oculomotor feature appears in advanced disease, perhaps in correspondence with the degenerative

Other oculomotor alterations include ofthalmoplegia, which usually appears at advanced disease in the 45% of the cases, although the severe saccadic slowing might overlook the frequency of ofthalmoplegia in SCA2. These patients have mild reduction of smooth pursuit gain in correspondence with the atrophy of cerebellar floculus (Ying et al., 2006) and the decrease of catch up saccades. The physiological and pathological nystagmus are very rare in SCA2 due to impaired ability to produce saccadic corrective phases. Some SCA2 patients have VOR responses with reduced gain (Burk et al., 1999; Rivaud-Pechoux et al., 1998;

Saccadic eye movements have also been used to evaluate the efficacy of therapeutical alternatives in Cuban SCA2 patients, such as neurorehabilitation (Rodríguez et al., 2008) and oral supplementation with zinc-sulphate (Velázquez-Pérez et al, 2011a). In both cases the saccadic latency decreased significantly after the therapies, but saccadic velocity and

For SCA2, the oculomotor function has not only evaluated in wake state, since the density of rapid eye movements (saccadic) during REM sleep was recently assessed. Both symptomatic and presymptomatic subjects show a marked decrease in this parameter, which is negatively correlated with the ataxia score in the patients (Velázquez-Pérez, et al., 2011b; Rodríguez-Labrada et al., 2011b). These findings suggest the usefulness of saccadic density during REM sleep as progression marker of the disease and reflect the extension of the oculomotor

Pathological nystagmus are prominent oculomotor signs of SCA3 patients. The frequency of gaze evoked and rebound nystagmus is approximately 90% (Jardim et al., 2001) being higher than those in SCA1, SCA2 and SCA6. Square wave jerks are usually reported in SCA3 subjects, unlike SCA1 and SCA2 individuals (Buttner et al, 1998; Burk et al., 1998). This oculomotor sign results from cerebellar disease and consists in small, horizontal, saccade-like movements that lead the eye away from the target trajectory and, after a delay,

Decreased VOR gain can be detected in majority of SCA3 patients and correlates with the CAG repeats, suggesting the pathologic involvement of the vestibular nuclei in the lateral brainstem. Furthermore, these patients show reduction of smooth pursuit and OKR gains with a presentation frequency above 70% in both cases (Buttner et al, 1998; Burk et al., 1998). Upon saccades, the main abnormality is saccadic dysmetria. Nevertheless, there are apparently conflicting data regarding the predominant type of dysmetria. Buttner et al., 1998 reported hypermetric saccades in 86% of the cases, while Rivauld-Pechoux et al., 1998, observed a predominance of hypometric (56%) over hypermetric saccades (18%). The disagreement can be explained by differences in the clinical stage of studied patients. In fact, the 81% of the patients recruited by Rivauld-Pechoux and colleagues had a moderate to severe motor disability, which could explain the higher prevalence of saccadic hypometria. Different to SCA2 and SCA1, decreased saccadic velocity is not a common feature of SCA3 patients (Burk et al., 1999; Rivaud-Pechoux et al., 1998; Buttner et al., 1998). This oculomotor feature appears in advanced disease, perhaps in correspondence with the degenerative

Buttner et al., 1998).

dysmetria were unchanged.

brainstem involvement to the sleep.

**3.3 Spinocerebellar ataxia type 3 (SCA3)** 

bring it back onto the target (Leigh & Zee, 2006).

changes seen in the raphe interpositus nucleus (Rub et al., 2003), a key structure of the brainstem premotor network that contains the omnipausas neurons, a group of cells that play an important role in determining the size of the velocity command for saccades, beside their well-known role as gating saccades (Miura & Optican, 2006). Also, internuclear and nuclear ophthalmoplegia is observed in 53% and 10% of the cases respectively. The latter is associated with a more severe disease course (Jardim et al., 2001).

Finally, the prolongation of saccadic latency occurs late in few cases (14%) (Buttner et al., 1998) and the performance in the antisaccadic paradigm shows an increase in the number of errors (Rivaud-Pechoux et al., 1998).

#### **3.4 Spinocerebellar ataxia type 6 (SCA6)**

Oculomotor function of SCA6 patients is characterized by signs of cerebellar and vestibular impairments such as horizontal and vertical nystagmus, abnormal smooth pursuit, saccadic dysmetria and abnormal VOR (Buttner et al., 1998; Christova et al., 2008; Bour et al., 2008). In comparison with other SCAs, the spontaneous downbeat nystagmus and square-wave jerks have the higher incidence in SCA6 subjects, whereas gaze-evoked nystagmus, rebound nystagmus and periodic alternating nystagmus are common features too (Buttner et al., 1998; Colen et al., 2008; Kim et al., 2010).

Patients with SCA6 have the more severe pursuit, OKN and VOR-fixed deficits among other polyglutamine SCAs but these oculomotor signs are not directly associated to CAG repeats or disease duration (Buttner et al., 1998). Vertical pursuit is impaired more than horizontal whereas downward pursuit more than upward (Bour et al., 2008).

The pattern of saccadic dysmetria in SCA6 is variable since these patients can show both hypometric and hypermetric saccades (Buttner et al., 1998; Bour et al., 2008). Although the decrease of saccadic velocity is not a prominent sign in these patients, it has been reported a mild saccadic slowing in some subjects both for the horizontal and vertical planes (Bour et al., 2008). These findings suggest functional extracerebellar impairment in the saccadic system and therefore are opposed to the paradigm of SCA6 as a "pure cerebellar syndrome." In fact, the screening of non-ataxia signs reveals a 25% of brainstem oculomotor signs (Schmitz-Hübsch, et al., 2008). In these patients the saccadic latency is normal (Buttner et al., 1998).

In 2009, Christova and co-workers studied the eye movement's abnormalities in both symptomatic and asymptomatic SCA6 cohorts and noticed that square-wave jerks, saccadic abnormalities and depressed smooth pursuit can be detected even before the disease onset. Among them, the square-wave jerks were the most prominent with an apparition frequency of 80% (Christova et al., 2008).

#### **3.5 Spinocerebellar ataxia type 7 (SCA7)**

The major saccadic alteration in this SCA is the slowing of saccades, together with saccadic dysmetria (Miller et al., 2009; Manrique et al., 2009). The decrease in saccadic velocity in SCA7 is associated with marked pontine atrophy that characterizes these patients from early stages of the disease and progresses to produce significant external ophthalmoplegia in patients with longer disease history (Bang et al., 2004; Martin et al., 1999). These alterations

Eye Movement Abnormalities in Spinocerebellar Ataxias 69

be noted (Verbeek et al., 2004; Verbeek, 2009). SCA25, SCA26 and SCA27 are characterized by pathological nystagmus in some patients, associated with slow eye movements in SCA25, abnormal pursuit in SCA26 and saccadic dysmetria in SCA27 (van Swieten, et al., 2003; Stevanin et al. 2004; Yu et al., 2005). SCA28 patients develop gaze-evoked nystagmus at early disease, while subjects with advanced disease have slowed saccades and ophthalmoparesis with frequency estimates of 60% and 80% respectively (Cagnoli et al., 2006). SCA29, which overlap with SCA15, is characterized by bilateral horizontal nystagmus (Dudding et al., 2004). In the case of SCA30, hypermetric saccades and gaze evoked nystagmus can be detected (Storey et al., 2009), as well as abnormal pursuit in SCA31 (Ishikawa et al., 2004). Finally, in a new SCA subtype recently identified by Wang et al., 2010

in two Chinese families, it was observed ocular dysmetria as main oculomotor sign.

Eye movement abnormalities are among the most common phenotypic manifestations of patients with SCAs. The most prominent oculomotor feature is the presence of pathological nystagmus in almost all subtypes, which is generally associated to abnormal smooth pursuit, saccadic dysmetria, impaired VOR/OKR, saccadic slowing and ophthalmoplegia. These oculomotor phenotypes are useful, but not determinant, for the differential diagnosis of SCAs. For example, the early and severe saccadic slowing with rare pathological nystagmus distinguishes SCA2 from SCA1, SCA3, SCA6, SCA17 and other SCA subtypes, whereas the marked abnormalities of smooth pursuit, VOR and OKR; in association with pathological nystagmus and rare saccadic slowing may help to define a SCA6 phenotype. Nevertheless, the notable overlapping of oculomotor features between SCA subtypes implies the requirement of other clinical criteria or the genetic testing for sensitively

The study of eye movement abnormalities allows the identification of several biomarkers useful in the clinical and research practice of SCAs. Some of the oculomotor disturbances precede the ataxia onset, being important preclinical markers to detect the early stages of the neurodegenerative process, to evaluate the genetic susceptibility of the asymptomatic relatives and to identify individuals close to ataxia onset for enrollment in preventive clinical trials and as potential outcome variables in these same trials. As most of the oculomotor abnormalities of SCAs are significantly accentuated with the advance of the disease, these can be used in monitoring clinical progression and therefore to assess the response to symptomatic treatments at short, medium or long term. The number of CAG repeats influences significantly on the saccadic slowing in SCA2 and the reduced VOR gain in SCA3 classifying these oculomotor features as sensitive biomarker of genetic damage, useful to evaluate the effect of modifying factors and therapeutic alternatives on the

Despite the above, still is necessary to deep more into the study of oculomotor function in SCAs. For example, vergence movements have not been studied, in spite of the known role of the cerebellum in these eye movements (Robinson & Fuchs, 2001) and the correspondent vergence deficits in patients with circumscribed cerebellar lesions (Sender et al., 2009). Moreover, further neuropathological, imaging and transcranial magnetic stimulation studies are required to focus the oculomotor system in order to provide more

**4. Conclusions** 

discriminating among these diseases.

polyglutamine toxicity.

may precede cerebellar and retinal manifestations and are among the earliest signs of the disease (Oh et al., 2001). In addition, some cases have difficulties to initiate the saccadic eye movements and may develop gaze evoked nystagmus (Miller et al., 2009; Manrique et al., 2009).

#### **3.6 Spinocerebellar ataxia type 17 (SCA17)**

The patients with SCA17 show hypometric saccades in correspondence with the marked reduction of Purkinje cells in the cerebellum (Hubner et al., 2007). The saccadic hypometria is increased with disease duration but neither with ataxia score nor the number of CAG repeats. In 26% of cases, there are transient saccadic decelerations and accelerations causing hypometric saccades with multiple steps. Clinical assessments have reported normal (Nakamura, 2001) or slowed saccades (Rolfs et al., 2003), although the hypometria or prematurely terminated saccades may conduce to the erroneous classification of slowed saccades. In these patients, the saccadic latency is normal, while antisaccades have a significant increase in the error rate (Hubner et al., 2007).

Smooth pursuit abnormalities in SCA17 patients include decrease of initial eye acceleration, which appears even in the asymptomatic and mildly affected SCA17 mutation carriers, reduced steady state velocity and prolongation of smooth pursuit latency. Smooth pursuit gain decreases with the disease duration and ataxia score, whereas the latency prolongation correlates positively with the ataxia score. Gaze-evoked nystagmus is not a prominent feature in SCA17 patients (Hubner et al., 2007).

#### **3.7 Other spinocerebellar ataxias**

With the exception of polyglutamine expansions SCAs, the oculomotor function of remaining SCAs has not been systematically studied while most of data result for clinical assessment. SCA5 is characterized by eye abnormalities owing to cerebellar impairments such as downbeat nystagmus and impaired smooth pursuit movements (Ranum et al., 1994; Ikeda et al., 2002). Similar features occur in SCA8, in addition to saccadic dysmetria (Day et al., 2000; Koob et al., 1999), and SCA10 (Zu et al., 2000; Grewal et al., 2002; Lin & Ashizawa, 2005). SCA11 is associated with horizontal and vertical nystagmus as well as jerky pursuit (Worth et al., 1999), while approximately one third of SCA12 patients can develop saccadic slowing, abnormal smooth pursuits or pathological nystagmus (Worth et al., 1999, Fujigasaki et al., 2001). Besides, in subjects affected with SCA13 is usual to observe horizontal nystagmus (Stevanin et al., 2005; Waters & Pulst, 2008).

Regarding SCA14, the main oculomotor disturbance is the hypermetria of downgaze and horizontal saccades, even from the early stages of the disease. Additionally, upwards gaze evoked nystagmus are common in patients with longer disease duration. Smooth pursuit movements and VOR are also impaired (Yamashita et al, 2000; Brkanac et al, 2002a; Fahey et al., 2005). Eye movement abnormalities of SCA15/16 and SCA18 include nystagmus for all these SCA subtypes associated to saccadic dysmetria in the first one (Miyoshi et al., 2001; Brkanac et al, 2002b; Gardner et al., 2005). In addition, hypermetric saccades into downgaze and lateral gaze are detected in some patients with SCA20 (Knight et al., 2004).

SCA22 patients show nystagmus and impaired smooth pursuit with intermittent corrective saccadic (Chung et al., 2003), while in SCA23 the ocular dysmetria and slowed saccades can be noted (Verbeek et al., 2004; Verbeek, 2009). SCA25, SCA26 and SCA27 are characterized by pathological nystagmus in some patients, associated with slow eye movements in SCA25, abnormal pursuit in SCA26 and saccadic dysmetria in SCA27 (van Swieten, et al., 2003; Stevanin et al. 2004; Yu et al., 2005). SCA28 patients develop gaze-evoked nystagmus at early disease, while subjects with advanced disease have slowed saccades and ophthalmoparesis with frequency estimates of 60% and 80% respectively (Cagnoli et al., 2006). SCA29, which overlap with SCA15, is characterized by bilateral horizontal nystagmus (Dudding et al., 2004). In the case of SCA30, hypermetric saccades and gaze evoked nystagmus can be detected (Storey et al., 2009), as well as abnormal pursuit in SCA31 (Ishikawa et al., 2004). Finally, in a new SCA subtype recently identified by Wang et al., 2010 in two Chinese families, it was observed ocular dysmetria as main oculomotor sign.

#### **4. Conclusions**

68 Spinocerebellar Ataxia

may precede cerebellar and retinal manifestations and are among the earliest signs of the disease (Oh et al., 2001). In addition, some cases have difficulties to initiate the saccadic eye movements and may develop gaze evoked nystagmus (Miller et al., 2009; Manrique et al.,

The patients with SCA17 show hypometric saccades in correspondence with the marked reduction of Purkinje cells in the cerebellum (Hubner et al., 2007). The saccadic hypometria is increased with disease duration but neither with ataxia score nor the number of CAG repeats. In 26% of cases, there are transient saccadic decelerations and accelerations causing hypometric saccades with multiple steps. Clinical assessments have reported normal (Nakamura, 2001) or slowed saccades (Rolfs et al., 2003), although the hypometria or prematurely terminated saccades may conduce to the erroneous classification of slowed saccades. In these patients, the saccadic latency is normal, while antisaccades have a

Smooth pursuit abnormalities in SCA17 patients include decrease of initial eye acceleration, which appears even in the asymptomatic and mildly affected SCA17 mutation carriers, reduced steady state velocity and prolongation of smooth pursuit latency. Smooth pursuit gain decreases with the disease duration and ataxia score, whereas the latency prolongation correlates positively with the ataxia score. Gaze-evoked nystagmus is not a prominent

With the exception of polyglutamine expansions SCAs, the oculomotor function of remaining SCAs has not been systematically studied while most of data result for clinical assessment. SCA5 is characterized by eye abnormalities owing to cerebellar impairments such as downbeat nystagmus and impaired smooth pursuit movements (Ranum et al., 1994; Ikeda et al., 2002). Similar features occur in SCA8, in addition to saccadic dysmetria (Day et al., 2000; Koob et al., 1999), and SCA10 (Zu et al., 2000; Grewal et al., 2002; Lin & Ashizawa, 2005). SCA11 is associated with horizontal and vertical nystagmus as well as jerky pursuit (Worth et al., 1999), while approximately one third of SCA12 patients can develop saccadic slowing, abnormal smooth pursuits or pathological nystagmus (Worth et al., 1999, Fujigasaki et al., 2001). Besides, in subjects affected with SCA13 is usual to observe

Regarding SCA14, the main oculomotor disturbance is the hypermetria of downgaze and horizontal saccades, even from the early stages of the disease. Additionally, upwards gaze evoked nystagmus are common in patients with longer disease duration. Smooth pursuit movements and VOR are also impaired (Yamashita et al, 2000; Brkanac et al, 2002a; Fahey et al., 2005). Eye movement abnormalities of SCA15/16 and SCA18 include nystagmus for all these SCA subtypes associated to saccadic dysmetria in the first one (Miyoshi et al., 2001; Brkanac et al, 2002b; Gardner et al., 2005). In addition, hypermetric saccades into downgaze

SCA22 patients show nystagmus and impaired smooth pursuit with intermittent corrective saccadic (Chung et al., 2003), while in SCA23 the ocular dysmetria and slowed saccades can

and lateral gaze are detected in some patients with SCA20 (Knight et al., 2004).

2009).

**3.6 Spinocerebellar ataxia type 17 (SCA17)** 

significant increase in the error rate (Hubner et al., 2007).

horizontal nystagmus (Stevanin et al., 2005; Waters & Pulst, 2008).

feature in SCA17 patients (Hubner et al., 2007).

**3.7 Other spinocerebellar ataxias** 

Eye movement abnormalities are among the most common phenotypic manifestations of patients with SCAs. The most prominent oculomotor feature is the presence of pathological nystagmus in almost all subtypes, which is generally associated to abnormal smooth pursuit, saccadic dysmetria, impaired VOR/OKR, saccadic slowing and ophthalmoplegia. These oculomotor phenotypes are useful, but not determinant, for the differential diagnosis of SCAs. For example, the early and severe saccadic slowing with rare pathological nystagmus distinguishes SCA2 from SCA1, SCA3, SCA6, SCA17 and other SCA subtypes, whereas the marked abnormalities of smooth pursuit, VOR and OKR; in association with pathological nystagmus and rare saccadic slowing may help to define a SCA6 phenotype. Nevertheless, the notable overlapping of oculomotor features between SCA subtypes implies the requirement of other clinical criteria or the genetic testing for sensitively discriminating among these diseases.

The study of eye movement abnormalities allows the identification of several biomarkers useful in the clinical and research practice of SCAs. Some of the oculomotor disturbances precede the ataxia onset, being important preclinical markers to detect the early stages of the neurodegenerative process, to evaluate the genetic susceptibility of the asymptomatic relatives and to identify individuals close to ataxia onset for enrollment in preventive clinical trials and as potential outcome variables in these same trials. As most of the oculomotor abnormalities of SCAs are significantly accentuated with the advance of the disease, these can be used in monitoring clinical progression and therefore to assess the response to symptomatic treatments at short, medium or long term. The number of CAG repeats influences significantly on the saccadic slowing in SCA2 and the reduced VOR gain in SCA3 classifying these oculomotor features as sensitive biomarker of genetic damage, useful to evaluate the effect of modifying factors and therapeutic alternatives on the polyglutamine toxicity.

Despite the above, still is necessary to deep more into the study of oculomotor function in SCAs. For example, vergence movements have not been studied, in spite of the known role of the cerebellum in these eye movements (Robinson & Fuchs, 2001) and the correspondent vergence deficits in patients with circumscribed cerebellar lesions (Sender et al., 2009). Moreover, further neuropathological, imaging and transcranial magnetic stimulation studies are required to focus the oculomotor system in order to provide more

Eye Movement Abnormalities in Spinocerebellar Ataxias 71

Carlson KM, Andresen JM & Orr HT. (2009). Emerging pathogenic pathways in the

Christova P, Anderson JH & Gomez C. (2008). Impaired Eye Movements in Presymptomatic

Chung MY, Lu YC, Cheng NC & Soong BW. (2003). A novel autosomal dominant

Colen C, Ketko A, George E & Van Stavern G. (2008). Periodic alternating nystagmus and

Day JW, Schut LJ, Moseley ML, Durand AC & Ranum LP. (2000). Spinocerebellar ataxia type

Dudding TE, Friend K, Schofield PW, Lee S, Wilkinson IA & Richards RI. 2004. Autosomal

Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, et al. (1995). Autosomal

Durr A. (2010). Autosomal dominant cerebellar ataxias: polyglutamine expansions and

Estrada R, Galarraga J, Orozco G, Nodarse A & Auburger G. (1999). Spinocerebellar ataxia 2

Fahey MC, Knight MA, Shaw JH, McK Gardner RJ, du Sart D, Lockhart PJ, et al. (2005).

Federighi P, Cevenini G, Dotti MT, Rosini F, Pretegiani E, Federico A, et al. (2011).

Fernández-Ruiz J, Velásquez-Pérez L, Díaz R, Drucker-Colín R, Pérez-González R, et al.

Fujigasaki H, Verma IC, Camuzat A, Margolis RL, Zander C, Lebre AS, et al. (2001). SCA12

Gardner RJ, Knight MA, Hara K, Tsuji S, Forrest SM & Storey E. (2005). Spinocerebellar ataxia type 15. *The Cerebellum*, Vol.4, No.1, pp. 47–50, ISSN 1473-4230. Geiner S, Horn AK, Wadia NH, Sakai H & Buttner-Ennever JA. (2008). The neuroanatomical

Gierga K, Burk K, Bauer M, Orozco G, Auburger G, Schultz C, et al. (2005). Involvement of

beyond. *Lancet Neurology*, Vol.9, pp. 885–94, ISSN 1474-4422.

cerebellar ataxias. *Brain*, Vol.134, pp. 879–91, ISSN 1460-2156.

family. *Annals of Neurology*, Vol.49, pp.117-21, ISSN 0364-5134.

*Brain Research*, Vol.171, pp. 575-81. ISSN 1875-7855.

*Acta Neuropathologica*, Vol.109, pp. 617-31, ISSN 1432-0533.

*Neuro-Ophthalmology*, Vol.28, pp. 287–88, ISSN 1536-5166.

*Neurology*, Vol. 63, pp. 2288-2292, ISSN 0028-3878.

*Brain*, Vol.118, pp.1573-81, ISSN 1460-2156.

247-53, ISSN 1879-0380.

1293-1299, ISSN 0006-8950.

pp. 306-10, ISSN 1432-0533.

pp. 2692-98, ISSN 0028-3932.

ISSN 1468-330X.

1538-3687.

547X.

spinocerebellar ataxias. *Current Opinion in Genetics* & *Development*, Vol.19, No.3, pp.

Spinocerebellar Ataxia Type 6. *Archives of Neurology*, Vol.65, No.4, pp. 530-6, ISSN

spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. *Brain*, Vol.126, Pp.

periodic alternating skew deviation in spinocerebellar ataxia type 6. *Journal of* 

8: clinical features in a large family. *Neurology*, Vol.55, No.5, pp.649–57, ISSN 1474-

dominant congenital non-progressive ataxia overlaps with the SCA15 locus.

dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families.

(SCA2): morphometric analyses in 11 autopsies. *Acta Neuropathologica*, Vol.97, No.3,

Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene. *Journal of Neurology, Neurosurgery and Psychiatry*, Vol.76, pp. 1720–22,

Differences in saccade dynamics between spinocerebellar ataxia 2 and late-onset

(2007). Prism adaptation in spinocerebellar ataxia type 2. *Neuropsychologia*, Vol.45,

is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian

basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). *Progress in* 

the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2).

insight on eye movement abnormalities and its potential role as therapeutic biomarkers in SCAs.

#### **5. Acknowledgements**

We are very indebted to Cuban Ministry of Public Health and to the Iberoamerican Multidisciplinary Network for the Movement Disorders Study: Parkinson disease and Spinocerebellar Ataxias. (RIBERMOV, abbreviation in Spanish).

#### **6. References**


insight on eye movement abnormalities and its potential role as therapeutic biomarkers in

We are very indebted to Cuban Ministry of Public Health and to the Iberoamerican Multidisciplinary Network for the Movement Disorders Study: Parkinson disease and

Aw ST, Haslwanter T, Halmagyi GM, Curthoys IS, Yavor RA & Todd MJ. (1996). Three-

Bahill AT, Clark MR & Stark L. (1975) The main sequence, a tool for studying human eye movements. *Mathematical Biosciences*, Vol.24, pp. 191–204, ISSN 0025-5564. Bang OY, Lee PH, Kim SY, Kim HJ & Huh K. (2004). Pontine atrophy precedes cerebellar

Brkanac Z, Bylenok L, Fernandez M, Matsushita M, Lipe H, Wolff J, et al. (2002a). A new

Brkanac Z, Fernandez M, Matsushita M, Lipe H, Wolff J, Bird TD & Raskind WH. (2002b).

Bruce CH & Friedman HR. (2002). Eye Movements. *Encyclopedia of the Human Brain*, Vol. 2,

Burk K, Fetter M, Abele M, Laccone F, Brice A, Dichgans J, et al. (1999). Autosomal

Buttner-Ennever JA, Wadia NH, Sakai H & Schwendeman G. (1985) Neuroanatomy of

slow saccades. Journal of Neurology, Vol.232, Suppl 285, ISSN 0340-5354 Cancel G, Durr A, Didierjean O, Imbert G, Burk K, Lezin A, et al. (1997). Molecular and

Cagnoli C, Mariotti C, Taroni F, Seri M, Brussino A, Michielotto C, et al. (2006). SCA28, a

*Molecular Genetics*, Vol.6, No.5, pp. 709-15, ISSN 1460-2083.

q11.2. *Brain*. Vol.129, pp. 235-42, ISSN 1460-2156.

dimensional vector analysis of the human vestibuloocular reflex in response to high-acceleration head rotations. I. Responses in normal subjects. *Journal of* 

degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis. *Journal of Neurology Neurosurgery and Psychiatry*, Vol.75, No.10, pp. 1452-6, ISSN 1468-330X. Bour LJ, van Rootselaar AF, Koelman JH & Tijssen MA. (2008). Oculomotor abnormalities in

myoclonic tremor: a comparison with spinocerebellar ataxia type 6. *Brain*, Vol.131,

dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. *Archives of* 

Autosomal dominant sensory/motor neuropathy with Ataxia (SMNA): Linkage to chromosome 7q22-q32. *American Journal of Medical Genetics*, Vol.114, No.4, pp. 450-

dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3*. Journal of Neurology*, Vol.246, No.9, pp. 789-97, ISSN 0340-5354. Buttner JA, Geschwind D, Jen JC, Perlman S, Pulst SM & Baloh RW.(1998). Oculomotor

phenotypes in autosomal dominant ataxias. *Archives of Neurology*, Vol.55, No.10, pp.

oculomotor structures in olivopontocerebellar atrophy (OPCA) patient with

clinical correlations in spinocerebellar ataxia 2: a study of 32 families. *Human* 

novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-

Spinocerebellar Ataxias. (RIBERMOV, abbreviation in Spanish).

*Neurophysiology*, Vol.76, pp. 4009-20, ISSN 1522-1598.

*Neurology*, Vol.59, No.8, pp. 1291-95, ISSN 1538-3687.

pp. 2295-303, ISSN 1460-2156.

57, ISSN 0148-7299.

1353-7, ISSN 1538-3687.

pp. 269-97.

SCAs.

**5. Acknowledgements** 

**6. References** 


Eye Movement Abnormalities in Spinocerebellar Ataxias 73

Leigh RJ & Kennard C. (2004). Using saccades as a research tool in the clinical

Leigh RJ & Zee DS. (2006). *The neurology of eye movements* (4th Ed), Oxford University Press,

Lencer R & Trillenberg P. (2008). Neurophysiology and neuroanatomy of smooth pursuit in

Lin X & Ashizawa T. (2005). Recent progress in spinocerebellar ataxia type-10 (SCA10). *The* 

Matilla-Dueñas A, Goold R & Giunti P. (2008) Clinical, genetic, molecular, and

Manrique RK, Noval S, Aguilar-Amat MJ, Arpa J, Rosa I & Contreras I. (2009). Ophthalmic

Martin J, Van Regemorter N, Del-Favero J, Lofgren A & Van Broeckhoven C. (1999).

Miller R, Tewari A, Miller J, Garbern J & Van Stavern GP. (2009). Neuro-ophthalmologic

Miura K & Optican LM. (2006). Membrane channel properties of premotor excitatory burst

Miyoshi Y, Yamada T, Tanimura M, Taniwaki T, Arakawa K, Ohyagi Y, et al. (2001). A novel

Müri RM & Nyffeler T. (2008) Neurophysiology and neuroanatomy of reexive and

Mustari MJ, Ono S & Das VE. (2009) Signal Processing and Distribution in Cortical-

Nakamura K. (2001). SCA17, a novel polyglutamine disease caused by the expansion of

Oh AK, Jacobson KM, Jen JC & Baloh RW. (2001). Slowing of voluntary and involuntary

Orozco DG, Estrada R, Perry T, Araña J & Fernández R. (1989). Dominantly inherited

Pierrot-Deseilligny C, Mileab D & Müri RM. (2004). Eye movement control by the cerebral cortex. *Current opinion in neurology*, Vol.17, pp. 17-25, ISSN 1350-7540. Prsa M. & Their P. (2011) The role of the cerebellum in saccadic adaptation as a window into

*of Computational Neuroscience*, Vol.20, pp.25–41, ISSN 1573-6873.

24.1. *Neurology, Vol.*57, No.1, pp. 96-100, ISSN 1526-632X.

*Academy of Sciences*, Vol.1164, pp. 147–154, ISSN 0077-8923.

pathophysiological insights into spinocerebellar ataxia type 1. *The Cerebellum*, Vol. 7

Features of Spinocerebellar Ataxia Type 7. *Journal of Neuro-Opthalmology*, Vol.29,

Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family. *Journal of the Neurological Sciences*, Vol.168,

features of spinocerebellar ataxia type 7. *Journal of Neuro-Ophthalmol*, Vol.29, pp.

neurons may underlie saccade slowing after lesions of omnipause neurons. *Journal* 

autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-

volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS). *Brain and Cognition, Vol.*68, pp. 284–292,

Brainstem Pathways for Smooth Pursuit Eye Movements. *Annals of New York* 

polyglutamine tracts in TATA-binding protein. *Rinsho Shinkeigaku*, Vol.41, pp.

saccades: an early sign in spinocerebellar ataxia type 7. *Annals of Neurology*, Vol.49,

olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological and biochemimical findings. *Journal of the Neurological Sciences*, Vol.93, pp. 37-50, ISSN

neural mechanisms of motor learning. *European Journal of Neuroscience*, Vol.33, pp.

neurosciences. *Brain*, Vol.127, pp. 460–77, ISSN 1460-2156.

*Cerebellum*, Vol. 4, pp. 37–42, ISSN 1473-4230.

humans. *Brain and Cognition*, Vol.68, pp. 219–28, ISSN 1090-2147.

New York, USA.

pp. 106-114, ISSN 1473-4222.

pp. 174-9, ISSN 1536-5166.

180–86, ISSN 1536-5166.

ISSN 1090-2147.

1123–25.

0022-510X.

No.1, pp. 37-46, ISSN 0022-510X.

No.6, pp. 801-4, ISSN 1531-8249.

2114–2128, ISSN 0953-816X.


Grewal RP, Achari M, Matsuura T, et al. (2002). Clinical features and ATTCT repeat

Harding AE. (1983). Classication of the hereditary ataxias and paraplegias. *The Lancet*,

Hikosaka O, Takikawa Y & Kawagoe R. (2000). Role of the basal ganglia in the control of

Holmes SE, O'Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C, et

Hubner J, Sprenger A, Klein C, Hagenah J, Rambold H, Zuhlke C, et al. (2007). Eye

Ikeda Y, Dick KA, Weatherspoon MR, Gincel D, Armbrust KR, Dalton JC et al. (2006).

Ishikawa K, Toru S, Tsunemi T, Li M, Kobayashi K, Yokota T, et al. (2005). An autosomal

(CAG)n. *Archives of Neurology*, Vol.58, No.6, pp. 899-904, ISSN 1538-3687. Karatas M. (2009). Internuclear and supranuclear disorders of eye movements: clinical

Kim JM, Lee JY, Kim HJ, Kim JS, Kim YK, Park SS, et al. (2010). The wide clinical spectrum

*Neurology, Neurosurgery and Psychiatry*, Vol.81, pp. 529–32, ISSN 1468-330X. Klostermann W, Zuhlke C, Heide W, Kompf D & Wessel K. (1997). Slow saccades and other

Knight MA, Gardner RJ, Bahlo M, Matsuura T, Dixon JA, Forrest SM, et al. (2004).

Kremlacek J, Valis M, Masopust J, Talab R, Kuba M, Kobova Z, et al. (2011). An

Kulkarni SA & Wadia NH. (1975) Model of an oculomotor subsystem. *International Journal of* 

Le Pira F, Zappala G, Saponara R, Domina E, Restivo DA, Regio E, et al. (2002). Cognitive

90, ISSN 1538-3687.

ISSN 0031-9333.

184–90, ISSN 1061-4036.

4036.

1331.

Vol.1, pp. 1151–55, ISSN 1474-547X.

Vol.69, No.11, pp. 1160-8, ISSN 0028-3878.

Vol.244, No.2, pp.105-11, ISSN 0340-5354.

*Nature Genetics*, Vol.21, pp. 379–84, ISSN 1061-4036.

(SCA2). *The Cerebellum,* Vol.10, pp. 32–42, ISSN 1473-4230.

*Biomedical Computation*, Vol6, pp. 1-21, ISSN 0020-7101.

expansion in spinocerebellar ataxia type 10. *Archives of Neurology*, Vol.59, pp. 1285–

purposive saccadic eye movements. *Physiological Reviews*, Vol.80, No.3, pp. 953-78,

al. (1999). Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. *Nature Genetics*, Vol.23, pp.391-92, ISSN 1061-

movement abnormalities in spinocerebellar ataxia type 17 (SCA17). *Neurology*,

Spectrin mutations cause spinocerebellar ataxia type 5. *Nature Genetics*, Vol.38, pp.

dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5' untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains. American Journal of Humab Genetics, Vol.77, No.2, pp. 280-96, ISSN 0002-9297. Jardim LB, Pereira ML, Silveira I, Ferro A, Sequeiros J & Giugliani R. (2001). Neurologic

findings in Machado-Joseph disease: relation with disease duration, subtypes, and

features and causes. *European Journal of Neurology*, Vol.16, pp.1265–77, ISSN 1468-

and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6*. Journal of* 

eye movement disorders in spinocerebellar atrophy type 1. *Journal of Neurology*,

Dominantly inherited ataxia and dysphonia with dentate calcication: spinocerebellar ataxia type 20. *Brain*, Vol.127, No. 5, pp. 1172–81, ISSN 1460-2156. Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, et al. (1999). An

untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8).

Electrophysiological Study of Visual Processing in Spinocerebellar Ataxia Type 2

findings in spinocerebellar ataxia type 2: Relationship to genetic and clinical variables *Journal of the Neurological Sciences*, Vol.201, pp. 53–7, ISSN 0022-510X.


Eye Movement Abnormalities in Spinocerebellar Ataxias 75

Seifried C, Velazquez-Perez L, Santos-Falcon N, Abele M, Ziemann U, Almaguer LE, et al.

Soong BW & Paulson HL. (2007). Spinocerebellar ataxias: an update. *Current Opinion in* 

Sparks DL. (2002). The brainstem control of saccadic eye movements. *Nature Reviews* 

Stevanin G, Bouslam N, Thobois S, Azzedine H, Ravaux L, Boland A, et al. (2004).

Stevanin G, Durr A, Benammar N & Brice A. (2005). Spinocerebellar ataxia with mental retardation (SCA13). *The Cerebellum*, Vol.4, No.1, pp. 43-46, ISSN 1473-4222. Storey E, Bahlo M, Fahey M, Sisson O, Lueck CJ & Gardner RJ. (2009). A new dominantly

Strupp M, Hüfner K, Sandmann R, Zwergal A, Dieterich M, Jahn K, et al. (2011). Central

Cerebellum. *Deutsches Ärzteblatt International*, Vol.108, No.12, pp. 197–204. Thurtell MJ, Tomsak RL & Leigh RJ. (2007). Disorders of saccades. *Current neurology and* 

Tusa R. & D. Zee. (1989). Cerebral control of smooth pursuit and optokinetic nystagmus. *Current Opinion in Ophthalmology*. Vol.2, pp. 115–146, ISSN 1531-7021. Vale J, Bugalho P, Silveira I, Sequeiros J, Guimaraes J & Coutinho P. (2010). Autosomal

van Swieten JC, Brusse E, de Graaf BM, Krieger E, van de Graaf R, de Koning I, et al. (2003).

Velázquez L (2008). *Ataxia Espinocerebelosa tipo 2. Principales aspectos neurofisiológicos para el* 

Velazquez Perez L, Cruz GS, Santos Falcon N, Enrique Almaguer Mederos L, Escalona

Velazquez-Perez L, Seifried C, Abele M, Wirjatijasa F, Rodriguez-Labrada R, Santos-Falcon

ataxia 2. *Annals of Neurology*, Vol.56, No.3, pp. 444-47, ISSN 1531-8249. Velázquez-Pérez L, Rodríguez-Chanfrau J, García-Rodríguez JC, Sánchez-Cruz G, Aguilera-

*Neuroscience Letters*, Vol.454, No.2, pp. 157-60, ISSN 0304-3940.

Vol.20, pp. 1–9, ISSN 0959-4388.

1331.

*Neurology*, Vol.20, No.4, pp. 438-46, ISSN 1350-7540.

*Psychiatry*, Vol.80, pp. 408–11, ISSN 1468-330X.

No.1, pp. 191-99, ISSN 0002-9297.

202-3, Holguín, Cuba.

*Neuroscience*, Vol.3, No.12, pp. 952-64, ISSN 1471-0048.

*Annals of Neurology*, vol.55, No.1, pp. 97-104, ISSN 0364-5134.

*neuroscience reports*,Vol.7, No.5, pp. 407-16, ISSN 1528-4042.

(2005). Saccade velocity as a surrogate disease marker in spinocerebellar ataxia type 2. *Annals of New York Academy of Sciences*, Vol.1039, pp. 524-7, ISSN 0077-8923. Shires J, Joshi S & Basso MA. (2010). Shedding new light on the role of the basal ganglia-

superior colliculus pathway in eye movements. *Current Opinion in Neurobiology*,

Spinocerebellar ataxia with sensory neuropathy (SCA25) maps to chromosome 2p.

inherited pure cerebellar ataxia, SCA 30. *Journal of Neurology Neurosurgery and* 

Oculomotor Disturbances and Nystagmus. A Window Into the Brainstem and

dominant cerebellar ataxia: frequency analysis and clinical characterization of 45 families from Portugal. *European Journal of Neurology*, Vol.17 pp. 124–28, ISSN 1468-

A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. *American Journal of Human Genetics*, Vol.72,

*diagnóstico y pronóstico de la Enfermedad*, (2nd Ed), Ediciones Holguín, ISBN 959-221-

Batallan K, Rodríguez Labrada R, et al. (2009a). Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin.

N, et al. (2009b). Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. *Clinical Neurophysiology*, Vol.120, No.3, pp. 632-35, ISSN 1388-2457. Velazquez-Perez L, Seifried C, Santos-Falcon N, Abele M, Ziemann U, Almaguer LE, et al.

(2004). Saccade velocity is controlled by polyglutamine size in spinocerebellar

Rodríguez R, et al. (2011a). Oral Zinc Sulphate Supplementation for Six Months in


Pula JH, Gomez CM & Kattah JC. (2010). Ophthalmologic features of the common

Ramat S, Leigh RJ, Zee DS & Optican LM. (2007). What clinical disorders tell us about the

Ranum LP, Schut LJ, Lundgren JK, Orr HT & Livingston DM. (1994). Spinocerebellar ataxia

Rivaud-Pechoux S, Durr A, Gaymard B, Cancel G, Ploner CJ, Agid Y, et al. (1998). Eye

Rodríguez-Labrada R; Velázquez-Pérez L; Seigfried C; Canales-Ochoa N; Auburger G;

Rodríguez-Labrada R, Velázquez-Pérez L, Canales Ochoa N, et al. (2011b). Subtle Rapid Eye

Rüb U, Brunt ER, Gierga K, Schultz C, Paulson H, de Vos RA, et al. (2003). The nucleus

*Journal of Chemical Neuroanatomy*, Vol.25, No.2, pp.115-27, ISSN 0891-0618. Rüb U, Jen JC, Braak H & Deller T. (2008). Functional neuroanatomy of the human premotor

Sander T, Sprenger A, Neumann G, Machner B, Gottschalk S, Rambold H, et al. (2009).

Schmitz-Hübsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. (2008).

symptoms. *Neurology*, Vol.71, pp. 982-989, ISSN 1526-632X.

gene carriers. *Movement Disorders*, Vol.26, pp. 347-50, ISSN 1531-8257. Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, et al. (2003). Clinical features

*Neurological Sciences*, Vol.306, pp. 103-07, ISSN 0022-510X.

*of Neurology*, Vol.54, pp. 367–75, ISSN 1531-8249.

ataxia type I. *Annals of Neurology*, Vol.43, pp. 297-302, ISSN 1531-8249. Robinson FR & Fuchs AF. (2001). The role of the cerebellum in voluntary eye movements. *Annual Review of Neuroscience*, Vol.24, pp. 981-1004, ISSN 1545-4126. Rodríguez Díaz JC, Velázquez-Pérez L, Sanchez Cruz G, Almaguer Gotay D, Rodríguez

*Restauración Neurológica*, Vol.7, pp. 13-8.

chromosome 11. *Nature Genetics*, Vol. 8, pp. 280–84, ISSN 1061-4036. Reilly JL, Lencer R, Bishop JR, Keedy S & Sweeney JA. (2008). Pharmacological treatment

ISSN 1531-7021.

2156.

2147.

0077-8923.

1460-2156.

spinocerebellar ataxias. *Current Opinion in Ophtalmology*, Vol.21, No.6, pp. 447-53,

neural control of saccadic eye movements. *Brain*, Vol.130, pp. 10-35, ISSN 1460-

type 5 in a family descended from the grandparents of President Lincoln maps to

effects on eye movement control. *Brain and Cognition*, Vol.68, pp. 415-35, ISSN 1090-

movement abnormalities correlate with genotype in autosomal dominant cerebellar

Labrada R, Aguilera Rodríguez R, et al. (2008). Evaluation of Neurological Restoration in patients with Spinocerebellar Ataxia type 2. *Plasticidad &* 

Medrano-Montero J; et al. (2011a). Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions. *Journal of the* 

Movement sleep abnormalities in presymptomatic Spinocerebellar Ataxia type 2

and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). *Annals* 

raphe interpositus in spinocerebellar ataxia type 3 (Machado-Joseph disease).

oculomotor brainstem nuclei: insights from postmortem and advanced in vivo imaging studies. *Experimental Brain Research*, Vol.187, pp. 167-80, ISSN 0014-4819. Rufa & Federigh. (2011) Fast versus slow: different saccadic behaviour in cerebellar ataxias.

In Basic and Clinical Ocular Motor and Vestibular Research. Rucker J & Zee DS, Eds. Annals of the New York Academy of Sciences, Vol.1233, pp. 148–154. ISSN

Vergence deficits in patients with cerebellar lesions. *Brain*, Vol.132, pp. 103-15, ISSN

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia


**5** 

*1Cuba 2,3Germany* 

**Spinocerebellar Ataxia Type 2** 

Hans-Joachim Freund2 and Georg Auburger3

*2International Neuroscience Institute, Hannover, 3Section Experimental Neurology, Dept. Neurology, Goethe University Medical School, Frankfurt am Main,* 

Luis Velázquez-Pérez1, Roberto Rodríguez-Labrada1,

*1Centre for the Research and Rehabilitation of Hereditary Ataxias, Holguín,* 

The autosomal dominant cerebellar ataxias (ADCA) are a clinically, pathologically and genetically heterogeneous group of neurodegenerative disorders caused by degeneration of cerebellum and its afferent and efferent connections. The degenerative process may additionally involves the ponto- medullar systems, pyramidal tracts, basal ganglia, cerebral cortex, peripheral nerves (ADCA I) and the retina (ADCA II), or can be limited to the

The most common of these dominantly inherited autosomal ataxias, ADCA I, includes many Spinocerebellar Ataxias (SCA) subtypes, some of which are caused by pathological CAG trinucleotide repeat expansion in the coding region on the mutated gene. Such is the case for SCA1, SCA2, SCA3/MJD, SCA6, SCA7, SCA17 and Dentatorubral-pallidoluysian atrophy

Among the almost 30 SCAs, the variant SCA2 is the second most prevalent subtype worldwide, only surpassed by SCA3 (Schöls et al., 2004; Matilla et al., 2006; Auburger, 2011). The disorder was first recognized in India in 1971 by Wadia and Swami, who was intrigued by the early and marked slowing of saccade movements, associated to the cerebellar syndrome (Wadia & Swami, 1971). Contemporarily, in Cuba some neurologists were describing many families coming from the north-east region of the country with the same distinct clinical picture (Vallés et al., 1978). Subsequent epidemiological surveys in this Cuban region, Holguín province, focusing on the causes of the highest SCA2 prevalence rate worldwide found evidence for a founder effect (Orozco et al., 1989; Auburger et al., 1990;

The collective worldwide prevalence of SCAs is estimated at about 6 cases per 100,000 people, although much higher gures have been reported in particular populations (Schöls et al., 2004). In the case of SCA2, the global prevalence is unknown because the most of the

**1. Introduction** 

cerebellum (ADCA III) (Harding et al., 1993).

(DRPLA) (Matilla et al., 2006).

Velázquez-Pérez et al., 2001, 2009a).

**2. Epidemiology** 

SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. *Neurochemical Research*, In press, ISSN 1573-6903.

